Login / Signup

Identification of actinomycin D as a specific inhibitor of the alternative pathway of peptidoglycan biosynthesis.

Yasushi OgasawaraYohei ShimizuYohei SatoTomoki YonedaYasuhide InokumaTohru Dairi
Published in: The Journal of antibiotics (2019)
Peptidoglycan is an indispensable component of bacterial cell walls. We recently discovered an alternative peptidoglycan biosynthetic pathway, which involves two enzymes, MurD2 and MurL, catalyzing the ligation of L-Glu to UDP-MurNAc-L-Ala and epimerization of the terminal L-Glu of the MurD2 product, respectively. Because the pathway operates in Xanthomonas oryze, a pathogen causing bacterial blight of rice, we searched for specific inhibitors from metabolites produced by actinomycetes to obtain a lead compound to function as an agrochemical. Actinomycin D was isolated from Streptomyces parvulus NBRC 13193 as a specific inhibitor of the pathway. In vitro analysis indicated that actinomycin D inhibited the MurD2 reaction.
Keyphrases
  • single cell
  • ms ms
  • cell therapy